Wyeth, John

Laboratorio Prodotti Biologici Braglia SpA British Patent 1,3B0,507 January 15,1975 Brown, K. U.S.Patent 3,476,766 November 4,1969 assigned to John Wyeth Brother Ltd. 

Cavalla, J.F. and White, A.C. British Patent 1,285,025 August 9,1972 assigned to John Wyeth Brother Ltd. 

Prominent scientists of the pharma industry, such as Malcolm McCoss, Merck John Lamattina, Pfizer Robert Ruffolo, Wyeth Steven Paul, and Lilly Research Labs who were interviewed by Chemical Engineering News [1], did not provide a clear answer to the key question, which stakeholders, shareholders, and patients alike, are most worried about Will the new tools of pharma R D allow the industry to also collect the high-hanging fruit, namely, new therapeutic categories like Alzheimer s disease, different forms of cancer, metabolic syndromes, and multiple sclerosis, which develop over... 

Many individuals in the pharmaceutical industry provided important information about the corporate regulatory affairs function, which helps manage relations with FDA. Thanks go especially to Bruce Burlington of Wyeth Franklin Top of Medimmune, who chaired the expert panel that advised DoD on vaccines and John Dingerdissen, then with Merck Vaccines. 

ALESSE 28 (levonorgestrel and ethinyl estradiol tablets) Wyeth April 2004 labeling Precautions. Drug Interactions Herbal products containing St. John s wort H. perforatum) may induce hepatic enzymes (CYP) and P-gp transporter and may reduce the effectiveness of contraceptive steroids. This may also result in breakthrough bleeding ... 

High Court. XYZ and others (Claimants) versus (1) Schering Health Care Limited, (2) Organon Laboratories Limited and (3) John Wyeth Brother Limited. Judgement by the Hon. Mr Justice Mackay. London, 29 July 2002. Case No 0002638. Neutral Citation No (2002) EWHC 1420 (QB). 

F. St. John Forbes Wyeth Labs, Pearl River, New York, U.S.A. 

Weston G.O. US Patent No. 4,190,584 Feb. 26, 1980 Assigned to John Wyeth and Brother Limited, Maidenhead, England Brown K. US Patent No. 3,578,671 May 11, 1971 Assigned to John Wyeth and Brother Limited, Taplow, Maidenhead, Berkshire, England... 

This operation was performed for late carotid rupture following neck trauma in an attempted suicide. The first successful ligation for carotid aneurysm was performed five years later in London by Astley Cooper (Cooper 1836). By 1868, Pilz was able to collect 600 recorded cases of carotid ligation for cervical aneurysm or hemorrhage, with an overall mortality of 43% (Hamby 1952). In 1878, an American surgeon named John Wyeth reported a 41% mortality in a collected study of 898 common carotid ligations, and contrasted this with a 4.5% mortality for ligation of the external carotid artery. 

LA. Cliffe, US Patent 5,541,326 (July 30, 1996) Assignee John Wyeth Brother, Limited Utility Treatment of Anxiety... 

John Wyeth and Brother of Philadelphia, in a 1901 catalog, listed a saw palmetto compound that also contained kola nut, parsley seed, and coca leaves. They recommend it for urinary complaints, prostatic irritation, and catarrhal conditions, and as an aphrodisiac. Major pharmaceutical companies, including Lilly, Squibb, and Merck, all produced products from this aromatic berry. 

Anonymous. An Epitome of Therapeutics. Philadelphia John Wyeth and Brother Inc., 1901. 

The major American core companies were, as industry historian Jonathan Libeneau describes them, large wholesaler/producers who offer a full range of standard preparations, that is, proprietary drugs to pharmacists, dmg-gists, and other retailers. In 1885, Liebenau writes, a buyer could choose between Merck, SmithKline, Parke Davis, Eli Lilly, Sterns, Schieffelen, John Wyeth, Upjohn, Mulford, Sharp Dohme and many others for a complete line of basic medicines in convenient forms. 

Shortly after this, about 1872, Messrs. John Wyeth and Brother, in conjunction with Mr. Henry Bower, succeeded in producing a machine which, while still a handpress, was so much of an advance over the previous patterns, that the cost of compression was materially reduced, and the resulting tablets were successfully exploited. 

Effexor (Figure 4.2) was developed by drug research scientists at Wyeth-Ayerst, John Yardley, Morris Husbands, and Eric Muth. Effexor development started in the early 1980s, at the same time Prozac was developed, but was released later than most of the other SSRIs, receiving FDA approval in 1993. 

---